Novo Nordisk CEO says experimental weight loss pill could become a best-in-class drug
[ad_1] Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company’s experimental weight loss pill, amycretin, could eventually become
Read More[ad_1] Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company’s experimental weight loss pill, amycretin, could eventually become
Read More[ad_1] Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in
Read More[ad_1] A closeup of Oura’s Gen3 Horizon ring and its sensors. Oura Oura will now sell its smart rings on
Read More[ad_1] Salesforce headquarters in San Francisco, California, US, on Wednesday, Nov. 29, 2023. David Paul Morris | Bloomberg | Getty
Read More[ad_1] Jonathan Raa | Nurphoto | Getty Images Novo Nordisk shares climbed 5% on Thursday morning, according to LSEG data,
Read More[ad_1] Cr | Istock | Getty Images Biotech company Viking Therapeutics has emerged as a strong potential entrant — or
Read More[ad_1] Dr. Marc Harrison, who’s now CEO of HATCo, speaking at the Healthy Returns conference in New York City on
Read More[ad_1] A container holding boxes of Mifepristone, the first medication in a medical abortion, are prepared for patients at Alamo
Read More[ad_1] Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but given the vast and
Read More[ad_1] The New York Stock Exchange with a Hims & Hers Health banner is pictured in the Manhattan borough of
Read More